Veterinary Stereotactic Radiosurgery System Market Size & Share 2024 to 2032

Veterinary Stereotactic Radiosurgery System Market Size

Veterinary Stereotactic Radiosurgery System Market size was valued at USD 412.3 million and is projected to grow at a CAGR of 9.3% from 2024 to 2032. The market's growth is due to the rising incidence of cancer in animals. With increased awareness of advanced treatment options, pet owners are seeking accurate and precise radiation therapies for treating their pets' cancerous tumors.

For example, middle-aged and older dogs, being more susceptible to tumors, benefit significantly from these non-invasive treatments. A study published in the Aging and Cancer Journal in February 2022 highlighted that one in four dogs would be diagnosed with cancer during their lifetime. Furthermore, research from Nature Journal in October 2021 identified cancer as a primary reason for veterinary consultations in the UK. This growing demand for specialized cancer care in dogs underscores the rising need for cancer therapies, driving the adoption of stereotactic radiosurgery systems. Such trends highlight the market's promising growth trajectory in the years ahead.
 

Stereotactic radiosurgery stands out as it delivers concentrated doses of radiation directly to tumors while safeguarding the surrounding healthy tissues. This precision makes it a preferred choice for cancer treatments. Additionally, advancements in imaging techniques and enhanced treatment planning systems are propelling the growth of this market.
 

A veterinary stereotactic radiosurgery system is a specialized device in veterinary medicine, designed to administer precise, high-dose radiation therapy for treating tumors in animals. It is especially effective for areas like the brain and spine. Leveraging innovative imaging and computer-guided technology, this non-invasive system targets tumors with sub-millimeter precision, significantly reducing potential harm to adjacent healthy tissues.
 

Veterinary Stereotactic Radiosurgery System Market Trends

The increasing focus on advancing cancer care and research for animals is expected to significantly drive market growth. Innovations in diagnostic and treatment technologies, such as AI-driven systems and advanced radiation therapies, are enhancing the precision and effectiveness of veterinary oncology, which in turn propels the demand for advanced systems. As pet owners and veterinary practices seek innovative solutions for cancer management, the demand for specialized equipment and services is likely to rise, fueling market growth.
 

the University of Wisconsin-Madison (UW-Madison) School of Veterinary Medicine has pioneered advancements in cancer care by becoming the first to treat an animal using the Radixact System equipped with Synchrony. This integration of AI-driven Synchrony with the Radixact System allowed for real-time tracking of the tumor's movement due to the animal's breathing, enabling automatic adjustments to the radiation beam to maintain precise targeting. This innovative approach underscores UW-Madison's commitment to enhancing veterinary oncology and improving patient outcomes.
 

Moreover, the growing animal healthcare expenditure, technological advancements in diagnostic systems, increasing number of stereotactic radiosurgery procedures, and strategic expansions by major players further propel market demand.
 

Veterinary Stereotactic Radiosurgery System Market Analysis

The market is segmented into linear accelerators (Linac), CyberKnife, and gamma knife. In 2023, the Linac segment emerged as the market leader, generating revenue of USD 199.3 million. With a projected CAGR of 9.1%, Linac is expected to maintain its dominance throughout the forecast period.
 

• The Linac segment's leadership is due to its versatility and precision.
   
• Linac systems excel in delivering targeted radiation therapy for various tumors, including brain, spinal, and others.
   
• With advanced imaging and treatment capabilities, Linac systems are ideal for a wide range of veterinary oncology applications.
   
• Moreover, their widespread adoption in veterinary hospitals and specialty clinics, driven by proven effectiveness and ongoing technological advancements, solidifies the Linac segment's top position in the market.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the veterinary stereotactic radiosurgery system market is categorized into brain tumors, spinal tumors, and other applications. In 2023, the brain tumors segment commanded a dominant market share of 59%, a trend anticipated to persist throughout the analysis period. 
 

• The brain tumor segment's dominance is attributed to the high prevalence of such tumors in animals, especially in dogs. 
   
• Utilizing the stereotactic radiosurgery system for these tumors ensures a precise, non-invasive treatment approach, significantly reducing harm to adjacent healthy tissues. 
   
• The high incidence of brain tumors in veterinary practices underscores the demand for advanced stereotactic radiosurgery technologies, tailored specifically for managing these tumors. The segment's prominence is a testament to its pivotal role in enhancing outcomes for affected animals. 
   
• For instance, estimates from Animal Cancer & Imaging Center highlight that brain tumors are notably more common in dogs than in other domestic species, with an incidence rate of about 14.5 cases per 100,000 dogs. While these tumors can manifest in dogs irrespective of age, breed, or sex, they predominantly occur in middle-aged and older dogs, especially those over five years. This heightened vulnerability in dogs underscores the urgent need for advanced diagnostic and treatment modalities, like stereotactic radiosurgery, propelling the demand for veterinary stereotactic radiosurgery systems and, in turn, driving market growth.
   

Based on the end-user, the veterinary stereotactic radiosurgery system market is divided into veterinary hospitals, veterinary clinics, and other end-users. In 2023, veterinary hospitals emerged as the dominant segment, capturing the largest market share.
 

• The supremacy of veterinary hospitals in the market is bolstered by their state-of-the-art infrastructure, access to the latest technologies, and their capability to provide specialized oncology services. 
   
• Equipped with advanced tools like linear accelerators and other stereotactic radiosurgery systems, these hospitals deliver precise and high-quality cancer treatments. 
   
• Moreover, the presence of trained specialists in these hospitals, adept at handling intricate cases, positions them as the preferred choice for pet owners seeking thorough cancer care for their animals. This blend of expertise and advanced resources solidifies the leading position of veterinary hospitals in the market.

In 2023, the U.S. led the North American veterinary stereotactic radiosurgery system market with a valuation of USD 152 million, and it is projected to experience significant growth throughout the analysis period.
 

• The U.S. dominance stems from its state-of-the-art veterinary healthcare infrastructure and a swift embrace of innovative technologies.
   
• Numerous specialized veterinary hospitals and research institutions in the U.S. leverage stereotactic radiosurgery systems to address intricate cancer cases in pets.
   
• Furthermore, the U.S. market leadership is bolstered by the presence of major technology providers and ongoing innovations in veterinary oncology.
   
• High rates of pet ownership and a readiness to invest in advanced treatments further fuel this demand.
   

Germany highlighted significant growth potential in the European veterinary stereotactic radiosurgery system market.
 

• Renowned for its strong veterinary healthcare sector, Germany is also an early adopter of innovative medical technologies.
   
• Veterinary clinics and research facilities across Germany routinely employ stereotactic radiosurgery systems to tackle various tumors in pets.
   
• Germany's emphasis on veterinary oncology, coupled with a robust regulatory framework, fosters the adoption of advanced treatment technologies.
   
• Consequently, the nation's focus on precision medicine and enhanced cancer care for pets solidifies its prominent market position.
   

The Asia Pacific veterinary stereotactic radiosurgery system market is set for swift expansion, boasting a projected CAGR of 9.7% during the forecast period.
 

• Factors driving this growth in the Asia-Pacific region include rapid advancements in animal healthcare, a surge in pet ownership, and heightened awareness of specialized cancer treatments.
   
• As emerging economies bolster their healthcare infrastructure, the region sees a rise in veterinary clinics and hospitals adopting innovative technologies, including stereotactic radiosurgery systems.
   
• The growing incidence of pet cancers, paired with a demand for effective, non-invasive treatments, underscores the region's rapid market growth.
   

Veterinary Stereotactic Radiosurgery System Market Share

The market is characterized by a few key players offering advanced technologies. The companies compete on technological innovation, precision, and effectiveness of their systems. Additionally, market players focus on expanding their offerings through strategic partnerships, research and development, and enhancing customer support to capture a larger share in the market.
 

Key players dominate the market, providing innovative technologies. These companies vie for supremacy through technological innovation, system precision, and overall effectiveness. Furthermore, to bolster their market share, players are broadening their offerings via strategic partnerships, investing in research and development, and amplifying customer support.
 

Veterinary Stereotactic Radiosurgery System Market Companies

Few of the prominent players operating in the veterinary stereotactic radiosurgery system industry include:

• Accuray Incorporated
• Elekta AB
• Varian Medical Systems
   

Veterinary Stereotactic Radiosurgery System Industry News:

• In January 2023, CVS Group installed a cutting-edge Elekta Infinity linear accelerator at its Bristol Vet Specialists referrals hospital. This advanced technology enables the hospital to provide state-of-the-art image-guided radiation therapy for cancer treatment in cats and dogs. This installation marks a significant step forward in enhancing cancer care for pets, positioning the hospital as a leader in veterinary oncology.
   

The veterinary stereotactic radiosurgery system market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Linear accelerators (Linac)
• CyberKnife
• Gamma knife

Market, By Application

• Brain tumor
• Spinal tumor
• Other applications

Market, By End-user

• Veterinary hospitals
• Veterinary clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa